Breaking News
January 22, 2018 - Mallinckrodt Completes Stannsoporfin New Drug Application Filing
January 22, 2018 - ACOG Backs ‘Cascade Testing’ for Cancer-Related Mutations
January 22, 2018 - The terrible toll tennis can take on top players who play too much
January 22, 2018 - KAIST scientists identify cellular mechanism for severe viral hepatitis
January 22, 2018 - New genomic tools provide better understanding of the human immune system
January 22, 2018 - Improving QoL with an App?
January 22, 2018 - First step toward CRISPR cure of Lou Gehrig’s disease
January 22, 2018 - Scientists uncover the proteins responsible for movement
January 22, 2018 - New clinical practice guideline provides recommendations for use of anticoagulants during heart surgery
January 22, 2018 - Depressive symptoms associated with poorer survival in patients with head and neck cancer
January 22, 2018 - Restaurant Bans Have Big Impact on Smoking Rates
January 22, 2018 - D.C. Week: CMS Outlines Path for Medicaid Work Mandate
January 22, 2018 - Study identifies new loci associated with asthma enriched in epigenetic marks
January 22, 2018 - New bug may reduce misery of hay fever sufferers
January 22, 2018 - Specially prepared supplement helps women to run faster, study shows
January 22, 2018 - 3-D Stent Retriever with Aspiration Proves Mettle in AIS
January 22, 2018 - Public health research seeks to understand how natural disasters impact spread of Zika
January 22, 2018 - Research reveals role of nanophenomenon in stimulating bone-repair process
January 22, 2018 - Drinking during late adolescence could be first step to liver problems in adulthood
January 22, 2018 - Epilepsy associated with volume and thickness differences in brain matter
January 22, 2018 - Trevena Announces FDA Acceptance for Review of New Drug Application for Olinvo (oliceridine) Injection
January 22, 2018 - A Noteworthy Margin of Error
January 22, 2018 - Firm advances human trials of revolutionary vaccine
January 22, 2018 - Many Indians put away treating orthopedic problems
January 22, 2018 - Cherwell releases new pocket guide to prepared culture media
January 22, 2018 - Huron earns ISO 13485 certification for quality management system
January 22, 2018 - Avion Pharmaceuticals Announces FDA Approval of Balcoltra (levonorgestrel and ethinyl estradiol tablets and ferrous bisglycinate tablets) Oral Contraceptive
January 22, 2018 - Multi-Gene Test For Early CVD; Neighborhood HF Risk; Novel Testosterone Drugs
January 22, 2018 - Skipping breakfast disrupts ‘clock genes’ that regulate body weight
January 22, 2018 - Creativity May Rely on ‘Teamwork’ in the Brain
January 22, 2018 - NeuroBreak: Alzheimer’s Germ Contest; High Salt Diet May Be Bad for Brain
January 22, 2018 - Diabetics may often fare poorly in hospice care
January 22, 2018 - Performance enhancing benefits of caffeine more apparent for infrequent tea, coffee drinkers
January 22, 2018 - HHS Unveils Framework for Interoperability
January 22, 2018 - More dentists to discuss risks of HPV-related cancers with their patients
January 21, 2018 - Research shows how Zika virus damages placenta to cause malformations in babies
January 21, 2018 - Achaogen Announces FDA Acceptance of New Drug Application with Priority Review for Plazomicin for Treatment of Complicated Urinary Tract Infections and Bloodstream Infections
January 21, 2018 - Drug Allergies: Time to Re-Test?
January 21, 2018 - Mitochondrial protein in cardiac muscle cells linked to heart failure, study finds
January 21, 2018 - Women more likely than men to die from a heart attack
January 21, 2018 - Next generation genomic sequencing can help detect pathogens after joint replacement
January 21, 2018 - Gov’t Shutdown Looms as Senate Debates Spending Bill
January 21, 2018 - Emergency Readiness for Older Adults and People with Disabilities
January 21, 2018 - Heart health at risk for Latinas over worries about deportation
January 21, 2018 - Scientists methodically identify genes related to blood feeding and non-biting mosquitoes
January 21, 2018 - Researchers discover potential target genes to halt thyroid cancer progression
January 21, 2018 - Youth with shared residency after parents’ divorce have less mental issues
January 21, 2018 - Sleep Better, Lose Weight? – Drugs.com MedNews
January 21, 2018 - More $$ Needed for Health Emergencies, Senators Told
January 21, 2018 - Gene test to predict breast cancer recurrence less cost effective in real world practice
January 21, 2018 - Study finds rise in number of adolescents receiving psychiatric or neurodevelopmental diagnosis
January 21, 2018 - Reminders can improve immunization rates
January 21, 2018 - A More Personalized Approach to PSA Screening in 2017
January 21, 2018 - T-cells engineered to outsmart tumors induce clinical responses in relapsed Hodgkin lymphoma
January 21, 2018 - Tetraphase Pharmaceuticals Announces Submission of New Drug Application to FDA for Eravacycline for the Treatment of Complicated Intra-Abdominal Infections (cIAI)
January 21, 2018 - Have Robotics Had a Detrimental Effect on Surgical Residency?
January 21, 2018 - Being bilingual may help autistic children
January 21, 2018 - Metrics Are Not Widespread in Rheumatoid Care
January 21, 2018 - Neuroanatomic abnormalities ID’d in those at risk for autism
January 21, 2018 - Children born with Down’s syndrome have superior genome that compensates for disability
January 21, 2018 - Study finds higher risks for asymptomatic paroxysmal AF patients
January 21, 2018 - The Second Stage of Diet Resolutions
January 21, 2018 - CT Scans Reduce Lung Cancer Deaths … But Among Whom?
January 21, 2018 - ADHD drug use soars among young women
January 21, 2018 - Researchers propose new regulation mechanism linked to action of SirT6 on chromatin
January 21, 2018 - Statins appear to reduce risk of repeated surgery in patients who undergo vitrectomy
January 21, 2018 - Morning Break: Hep A Outbreak Spreads; Tide Pod Challenge; Keeping Lobsters Out of Hot Water
January 21, 2018 - EULAR and ACR present SLE classification criteria at the 2017 ACR/ARHP Annual Meeting
January 21, 2018 - Progenics Pharmaceuticals Announces FDA Acceptance of New Drug Application for Azedra (iobenguane I 131) in Pheochromocytoma and Paraganglioma
January 21, 2018 - House Passes Funding Bill with 6-Year CHIP Renewal
January 21, 2018 - DASH ranked Best Diet Overall for eighth year in a row by U.S. News and World Report
January 21, 2018 - Dementia study sheds light on how damage spreads through brain
January 20, 2018 - Morning Break: Missing Maria Deaths; N.J. Doc Charged in Wife’s Murder; Viva Vaseline!
January 20, 2018 - No interventions proven to prevent late-life dementia
January 20, 2018 - Judge orders new Olympus trial over superbug death
January 20, 2018 - Don’t Rely on Just One Blood Pressure Test for Kids: Study
January 20, 2018 - Going Off the Deep End About Water
January 20, 2018 - Parental attention can reduce risk of drug abuse in adolescence
January 20, 2018 - Mast Uri System offers efficient and cost-friendly diagnostic solution
January 20, 2018 - International SOS, Chatham House sign partnership agreement to further advance Global Health Security Agenda
Blood take a look at might expect medicine results for sufferers with localized NSCLC

Blood take a look at might expect medicine results for sufferers with localized NSCLC

image_pdfDownload PDFimage_print

A brand new learn about demonstrates blood take a look at to come across most cancers might expect medicine results for sufferers with localized non-small cellular lung most cancers (NSCLC) and come up with the money for physicians further lead time to personalize medicine for recurrent illness. Sufferers within the learn about with detectable ranges of circulating tumor DNA (ctDNA) in a while after medicine all had recurrences inside of two years, whilst all however one of the vital sufferers with out detectable ctDNA in a while after medicine remained disease-free and survived long-term. Typical imaging, conversely, was once no longer prognostic for recurrence or survival. Findings will probably be offered as of late on the 59th Annual Assembly of the American Society for Radiation Oncology (ASTRO).

The competitive nature of lung most cancers could make long-term control particularly difficult. As a result of NSCLC has a tendency to development, even following medicine, common tracking for recurrence is essential. The CT scans in most cases used for tracking, then again, are steadily not able to come across microscopic tumor deposits or to tell apart standard tissue adjustments led to via medicine from adjustments led to via recurrent illness.

“Blood exams that may come across minute lines of most cancers that stay after medicine may just make stronger recurrence tracking and probably be offering physicians months of extra lead time to tailor therapies and make stronger our sufferers’ results and high quality of lifestyles,” stated Aadel Chaudhuri, MD, PhD, lead writer of the learn about and a major resident in radiation oncology at Stanford College in Palo Alto, California.

“Our findings recommend that ctDNA research, in contrast to CT scans, can determine in a while after medicine of completion if a affected person with localized lung most cancers has most probably been cured via radiation or surgical operation or if she or he nonetheless has most cancers cells provide of their frame. Whilst we anticipated that ctDNA detection of molecular residual illness would expect deficient scientific results, we had been shocked via how strongly predictive the take a look at was once for recurrence and survival.”

Presence of ctDNA was once measured as a marker of molecular residual illness (MRD) in sufferers with degree I-III NSCLC instantly earlier than medicine and in a while after medicine was once finished. ctDNA ranges additionally had been measured mid-treatment (reasonable = Three weeks, vary = 1.Four-Three.7 weeks) for part of the sufferers receiving chemoradiation (n = 13 of 27 sufferers). Most cancers Customized Profiling via Deep Sequencing (CAPP-Seq) was once used to evaluate whether or not ctDNA was once provide. Surveillance scans the use of CT imaging had been evaluated the use of the Reaction Analysis Standards In Forged Tumors (RECIST).

The median affected person age was once 67 years (vary 47-91 years), and maximum sufferers (67%) had been male. All 41 sufferers had been handled with healing intent, together with with chemoradiation remedy (66%), radiation remedy on my own (27%) and surgical operation on my own (7%). Median follow-up for the learn about was once 35 months (vary 7-56 months).

Researchers detected ctDNA pretreatment in 38 of the 41 sufferers (93%). Thirty-four of those 38 sufferers had blood drawn inside of 4 months of medicine of completion (the prespecified MRD landmark) and had been eligible for next research.

A few of the 34 sufferers with ctDNA MRD pretreatment, greater than part (56%, n = 19) had detectable residual illness after medicine. All of those sufferers therefore evolved recurrent lung most cancers, in comparison with most effective one of the vital 15 sufferers with out detectable ctDNA MRD.

Sufferers with detectable ctDNA MRD after medicine had worse freedom from development and survival than sufferers with out detectable ctDNA MRD (freedom from development Danger Ratio (HR) = 44.zero, p < zero.0001; disease-specific survival HR = 27.7, p < zero.0001). CT imaging on the identical time was once no longer prognostic for survival. ctDNA ranges earlier than medicine additionally weren't related to survival results.

In 8 of the 13 sufferers assessed mid-treatment, ctDNA accounted for zero.1 p.c or extra of all cell-free DNA. For those sufferers, mid-treatment ctDNA ranges predicted eventual illness development (HR = 2.7, p = zero.006). Sixty p.c of the sufferers with not up to zero.1 p.c ctDNA mid-treatment had been progression-free at two years following medicine, in comparison to not one of the sufferers with zero.1 p.c or upper ranges of ctDNA (HR = Four.Four, p = zero.037).

“Someday, clinicians could possibly use ctDNA research to spot sufferers who may just get pleasure from further medicine after first-line remedy,” stated Maximilian Diehn, MD, PhD, senior writer of the learn about and an assistant professor of radiation oncology at Stanford.

“In a similar learn about additionally offered at this yr’s ASTRO Annual Assembly, we discovered that ctDNA research detected illness recurrence a mean five.five months previous than standard-of-care CT imaging for localized lung most cancers and helped with interpretation of equivocal follow-up imaging. This implies that ctDNA research may just open a window to regard sufferers with residual most cancers early, whilst illness burden is minimum.”​

Tagged with:

About author

Related Articles